Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

3.0K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
3.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Usefulness of Clot Waveform Analysis-Activated Thromboplastin Time (APTT) for Diagnosing Thrombotic Diseases.

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·2026
Same author

Recognizing Coagulation Disorders in Sepsis in the Emergency Room: A Narrative Review.

Journal of clinical medicine·2026
Same author

Evaluation of Autoimmune FVIII Inhibitor Using Clot Waveform Analysis in Emicizumab-Treated Patients.

Journal of clinical medicine·2026
Same author

Diagnostic and Prognostic Evaluation of Disseminated Intravascular Coagulation Using the Disseminated Intravascular Coagulation Index.

Journal of clinical medicine·2025
Same author

Factors influencing antithrombin activity following supplementation in sepsis-associated disseminated intravascular coagulation.

Thrombosis journal·2025
Same author

Evaluation of Deficiency and Excessive Condition of Thrombin Burst Using Laboratory Tests.

Thrombosis and haemostasis·2025

Related Experiment Video

Updated: May 16, 2025

Leveraging Turbidity and Thromboelastography for Complementary Clot Characterization
06:28

Leveraging Turbidity and Thromboelastography for Complementary Clot Characterization

Published on: June 4, 2020

6.7K

Clinical Application of Clot Waveform Analysis.

Hideo Wada1, Katsuya Shiraki1, Yuhko Ichikawa2

  • 1Department of Laboratory and General Medicine, Mie Prefectural General Medical Center, Yokkaichi, Japan.

Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
|April 2, 2025
PubMed
Summary
This summary is machine-generated.

Clot waveform analysis (CWA) offers new diagnostic tools for clotting disorders. Modified CWAs show promise for monitoring hemophilia and anticoagulant therapy, and diagnosing various diseases.

Keywords:
APTTCFWACWAsTF/FIXasTT

More Related Videos

Author Spotlight: Advancing Thrombolytic Testing by Integrating Flow Dynamics in In Vitro Models
06:16

Author Spotlight: Advancing Thrombolytic Testing by Integrating Flow Dynamics in In Vitro Models

Published on: April 19, 2024

807
An In vitro System to Gauge the Thrombolytic Efficacy of Histotripsy and a Lytic Drug
07:50

An In vitro System to Gauge the Thrombolytic Efficacy of Histotripsy and a Lytic Drug

Published on: June 4, 2021

2.6K

Related Experiment Videos

Last Updated: May 16, 2025

Leveraging Turbidity and Thromboelastography for Complementary Clot Characterization
06:28

Leveraging Turbidity and Thromboelastography for Complementary Clot Characterization

Published on: June 4, 2020

6.7K
Author Spotlight: Advancing Thrombolytic Testing by Integrating Flow Dynamics in In Vitro Models
06:16

Author Spotlight: Advancing Thrombolytic Testing by Integrating Flow Dynamics in In Vitro Models

Published on: April 19, 2024

807
An In vitro System to Gauge the Thrombolytic Efficacy of Histotripsy and a Lytic Drug
07:50

An In vitro System to Gauge the Thrombolytic Efficacy of Histotripsy and a Lytic Drug

Published on: June 4, 2021

2.6K

Area of Science:

  • Hematology
  • Coagulation Diagnostics
  • Biomedical Engineering

Background:

  • Clot waveform analysis (CWA) provides insights into blood coagulation dynamics.
  • Existing methods like CWA-APTT have limitations in diagnosing clotting disorders.
  • Novel CWA variants are being developed to address these limitations and expand clinical utility.

Purpose of the Study:

  • To evaluate clot waveform analysis (CWA) for potential clinical applications.
  • To introduce and assess modified CWA techniques for enhanced diagnostic capabilities.
  • To explore the utility of CWA in managing specific patient populations and disease states.

Main Methods:

  • Analysis of activated partial thromboplastin time (CWA-APTT), diluted prothrombin time (CWA-dPT), and thrombin time (CWA-sTT) waveforms.
  • Development and evaluation of clot fibrinolysis waveform analysis (CFWA) incorporating tissue-type plasminogen activator.
  • Assessment of derivative curve characteristics (peak times and heights) in CWA.

Main Results:

  • CWA-APTT, while useful, has diagnostic limitations.
  • CWA-dPT effectively detects hypercoagulability.
  • CWA-sTT evaluates hemostatic abnormalities in patients on emicizumab.
  • CFWA assesses both clotting and fibrinolysis.

Conclusions:

  • Modified CWAs, including CWA-dPT, CWA-sTT, and CFWA, offer improved diagnostic potential.
  • Further investigation of CWA and its variants is warranted across diverse diseases.
  • Clinical applications include monitoring hemophilia and anticoagulant therapy, and differential disease diagnosis.